Table I.
Clinicopathological characteristics of patients with hepatocellular carcinoma.
| Characteristic | Value, n (%) |
|---|---|
| Gender | |
| Male | 35 (83.3) |
| Female | 7 (16.7) |
| Age | |
| Mean, years | 57.8 |
| <50 years | 5 (11.9) |
| ≥50 years | 37 (88.1) |
| HBsAg | |
| Present | 26 (61.9) |
| Absent | 16 (38.1) |
| Tumor size | |
| <5 cm | 29 (69.0) |
| ≥5 cm | 13 (31.0) |
| pT | |
| 1 | 31 (73.8) |
| 2 | 5 (11.9) |
| 3 | 6 (14.3) |
| Cirrhosis | |
| Present | 33 (78.6) |
| Absent | 9 (21.4) |
| E-S grade | |
| 1 | 8 (19.0) |
| 2 | 32 (76.2) |
| 3 | 2 (4.8) |
| Capsule invasion | |
| Present | 8 (19.0) |
| Absent | 34 (81.0) |
| Bile duct invasion | |
| Present | 3 (7.1) |
| Absent | 39 (92.9) |
| Histology | |
| Trabecular | 20 (47.6) |
| Mixeda | 18 (42.9) |
| Solid | 4 (9.5) |
| s-AFP | |
| <100 ng/ml | 31 (73.8) |
| ≥100 ng/ml | 11 (26.2) |
a
mixed form composed of pseudoglandular, trabecular and pseudograndular pattern. HBsAg, hepatitis B surface antigen; pT, pathological tumor stage; E-S, Edmonson-Steiner; s-AFP, serum α-fetoprotein.